Clinical Trial Update: Internal Radiation Therapy Plus Carmustine Implants in Treating Patients With Recurrent or Refractory Malignant Glioma [Phase 1]

View source ↗

Summary

This clinical trial update reports completion of a Phase 1 study evaluating internal radiation therapy combined with carmustine implants for recurrent or refrac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Glioma

Drugs mentioned

• GLIADEL wafer (carmustine)

Snippet

Sponsor: Barrett Cancer Center | Conditions: Brain and Central Nervous System Tumors | Phase 1 | Status: COMPLETED